ouverture
134.20
clôture veille
134.20
+ haut
134.40
+ bas
134.00
volume
13 478
valorisation
1 281 MEUR
capital échangé
0.14%
dernier échange
20.04.18 / 17:35:11
secteur
- Cotation de la valeur sur les autres places
Autres places de cotation
FermerNATUREX : Naturex denies any participation in the process to acquire the Diana Group
Avignon, 10th March 2014 - Naturex, the global leader in specialty plant-based natural ingredients, following rumours circulating in the media regarding the potential acquisition of the Diana Group, a French provider of natural ingredients for industry, in the interest of transparency, is obliged to issue a statement to its shareholders.
The financial media reported in January 2014 that the private equity firm Ardian (ex AXA Private equity) intended to accelerate the sale of Diana Group it had acquired in 2007.
Following recent references in the French and international press citing Naturex as a potential candidate to acquire Diana, the Group wishes to deny this information.
Irrespective of the above, Naturex will continue to pursue its own strategy for external growth by focusing on carefully targeted opportunities offering complementary fit with its businesses, expertise and positioning.
The Group will have an opportunity to outline this strategy in detail when it presents its 2013 annual results (SFAF analysts meeting), 2 April 2014 at 10:00 at NYSE Euronext in Paris.
You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com
- Next press release
- Annual results 31 March 2014
Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B
 |
Total number of shares comprising the share capital: 7 843 251 ISIN FR0000054694 NATUREX is a component of the CAC PME, CAC Small and Gaïa indexes. Naturex is eligible for the "long only" Deferred Settlement Service (SRD). Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY. SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY |
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 1,400 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
- Contacts
| Thierry Lambert Chairman and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 t.lambert@naturex.com |
Thierry Bertrand Lambert Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 t.b.lambert@naturex.com |
| Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-35106-cp-naturex_100314.pdf
| 0.00% |
Mes listes
valeur |
dernier |
var. |
|---|---|---|
| 8.294 | +1.74% | |
| 5412.83 | +0.39% | |
| 97.1 | +0.77% | |
| 14.135 | +0.32% | |
| 1.229 | -0.46% | |
| 21.62 | -1.01% | |
| 0.738 | +0.27% | |
| 17.9 | -0.17% | |
| 0.975 | +0.39% |
Vous devez être membre pour ajouter des commentaires.